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Robotic-Assistance Does Not Enhance Standard
Laparoscopic Technique for Right-Sided
Donor Nephrectomy
Xiaolong S. Liu, MD, Hadley W. Narins, BA, Warren R. Maley, MD,
Adam M. Frank, MD, Costas D. Lallas, MD
ABSTRACT
Objective: To examine donor and recipient outcomes
after right-sided robotic-assisted laparoscopic donor ne-
phrectomy (RALDN) compared with standard laparo-
scopic donor nephrectomy (LDN) and to determine
whether robotic-assistance enhances LDN.
Materials & Methods: From December 2005 to January
2011, 25 patients underwent right-sided LDN or RALDN.
An IRB-approved retrospective review was performed of
both donor and recipient medical charts. Primary end-
points included both intraoperative and postoperative
outcomes.
Results: Twenty right-sided LDNs and 5 RALDNs were
performed during the study period. Neither estimated
blood loss (76.4mL vs. 30mL, P.07) nor operative time
(231 min vs. 218 min, P.61) were significantly different
between either group (LDN vs. RALDN). Warm ischemia
time for LDN was 2.6 min vs. 3.8 min for RALDN (P.44).
Donor postoperative serum estimated glomerular filtration
rates (eGFR) were similar (53 vs. 59.6mL/min/1.73m2,
LDN vs. RALDN, P.26). For the recipient patients, post-
transplant eGFR were similar at 6 months (53.4 vs.
59.8mL/min/1.73m2, LDN vs. RALDN, P.53).
Conclusion: In this study, robotic-assistance did not im-
prove outcomes associated with LDN. Larger prospective
studies are needed to confirm any perceived benefit of
RALDN.
Key Words: Robotic donor nephrectomy, Laparoscopic
donor nephrectomy, Kidney transplant.
INTRODUCTION
Laparoscopic donor nephrectomy (LDN) was first intro-
duced in 1995 by Ratner and colleagues and has since
demonstrated both low donor morbidity as well as excel-
lent graft performance in recipient patients.1–4 Other ad-
vantages of LDN include decreased postoperative narcotic
requirements, lower intraoperative blood loss, shorter du-
ration of postoperative hospital stay, and improved cos-
metic results compared to that of conventional open pro-
cedures.5–8
Left-sided donor nephrectomy has been traditionally per-
formed, because left kidneys were acknowledged as the
preferred organ for transplantation while right-sided kid-
neys were reserved for instances where the left renal unit
was deemed unacceptable for transplantation (eg, aber-
rant left-sided vascular anatomy or size discrepancy ren-
dering the right kidney superior and thus more suitable for
transplantation).9,10 Fear of a resultant short renal vein and
renal vein graft thrombosis further dissuaded surgeons
from performing right-sided harvests.11,12 However, sev-
eral recent studies have demonstrated equivalent postop-
erative results between right- and left-sided LDN groups,
leading to an increasing number of centers now perform-
ing right-sided LDN to maximize the donor pool regard-
less of left-sided anatomy.13–16
With the introduction of the da Vinci Robotic Surgical
System (Intuitive Surgical, Sunnyvale, CA), robotic-as-
sisted laparoscopic renal surgery has gained popularity,
with the most popular procedures being radical and par-
tial nephrectomy. The facility of dissection around the
renal hilum provided by the robotic surgical system and its
importance in donor nephrectomy led investigators to
pursue robotic-assisted laparoscopic donor nephrectomy
(RALDN), an operation that has been reported to be safe
and successful for organ retrieval.17,18 However, these
studies have mainly been limited to left-sided donor ne-
phrectomy procedures.17 Also, no trials have compared
outcomes between RALDN and LDN techniques. In this
study, we report the donor and recipient outcomes of our
right-sided RALDN patients with comparison analysis to
the standard LDN technique.
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MATERIALS AND METHODS
Following IRB approval, a retrospective medical chart
review of all donor and matched recipients was per-
formed. Preoperative patient characteristics including age
at time of surgery and BMI were recorded for all donor
and recipient pairs. Donor renal vascular anatomy was
assessed preoperatively with fine cut contrast enhanced
computed tomography that included 3-dimensional re-
constructions. Intraoperative and postoperative data were
then subsequently collected. Primary endpoints included
estimated blood loss (EBL), operative duration (time start-
ing at patient positioning and ending with transportation
out of the operating room), warm ischemia time (WIT,
defined as time from clamping of the renal artery to
perfusion with preservation medium), occurrence of any
intraoperative complications, donor estimated glomerular
filtration rates (eGFR) at hospital discharge, total postop-
erative narcotic pain requirement, and length of hospital
stay (LOS). Estimated glomerular filtration rates were cal-
culated using the modification of diet in renal disease
formula based on patient age in years, gender, race, and
serum creatinine in mg/dL and reported in mL/min/
1.73m2.
All postoperative intravenous and oral narcotic pain med-
ication use was tallied and reported as a total oral mor-
phine equivalent dose (MED) in milligrams (mg) using a
validated on-line calculator (http://www.globalrph.com/
narcoticonv.htm).
For recipients, 1-week, 6-month, and 1-year posttrans-
plant serum creatinine levels were collected and eGFRs
were calculated. Any diagnosis of delayed graft function,
defined by anuria within the first 24 hours or need for
postoperative hemodialysis within one week, was noted
from the medical history.
All RALDNs were performed by a single urologic surgeon
using the da Vinci Robotic Surgical System. As with LDN,
patient positioning for RALDN was a modified 45° flank,
and the procedure was begun with placement of a hand
port through which pneumoperitoneum was established.
The hand port was not used for the dissection, but was
available for graft removal and in the case of any emer-
gencies. One extra working port was placed for RALDN,
an assistant port used for passage of a vascular stapler.
The approach to the dissection for RALDN did not differ
significantly from LDN. Finally, in our robotic procedures,
renal graft hilar vessels were ligated by the assistant using
an endovascular stapler passed through the aforemen-
tioned accessory port. LDNs were performed by both this
same urologic surgeon as well as 2 surgeons from the
Division of Transplantation Surgery in the Department of
Surgery at our institution. Surgical technique for LDN
differed slightly for each surgeon, but all involved initial
placement of a hand port for dissection and graft removal,
and ligation of the renal vessels with an endovascular
stapler. Surgeons from the aforementioned transplanta-
tion division performed all recipient surgeries.
Data points are reported as a mean or percentage where
appropriate. Two-tailed unpaired t tests and Fisher’s
exact tests were implemented to calculate statistical
significance (defined as a P-value .05, GraphPad
Prism Version 5.03, GraphPad Software 2236, Avenida
de la Playa La Jolla, CA).
RESULTS
Between December 2005 and January 2011, 160 minimally
invasive living donor nephrectomies were performed at
our institution. Of these, 135 were left-sided and 25 (16%)
were right-sided. Twenty-five matched recipient patients
underwent kidney transplantation utilizing the donated right
kidney obtained from the LDN and RALDN groups. Patient
and recipient demographics are reported in Table 1.
Mean patient ages between the 2 groups were similar
Table 1.
Donor and Recipient Patient Demographics
LDNa
(n20)
RALDNa
(n5)
P
Value
Donors
Age (years) 40.7 34.8 .20
BMIa 25.3 31.2 .01
Preoperative creatinine (mg/dL) 0.8 0.9 .64
Preoperative eGFR (mL/min/
1.73m2)
88.7 93.4 .65
Units with 1 Renal Artery 1 0 .63
Units with 1 Renal Vein 2 0 .48
Recipients
Age (years) 49.2 41.6 .53
BMIa 25 29.6 .04
Preoperative creatinine (mg/dL) 7.0 8.3 .42
Preoperative eGFR (mL/min/
1.73 m2)
9.4 8.0 .44
aLDN – Laparoscopic Donor Nephrectomy, eGFR – estimated
glomerular filtration rate, RALDN – Robotic-assisted Laparo-
scopic Donor Nephrectomy, BMI – Body Mass Index.
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(40.7 years vs. 34.8 years, P.20), while BMI was higher in
the RALDN group (31.2 vs. 25.3, P.01). Two donor
kidneys in the LDN group had 2 renal veins while one
kidney had 2 renal arteries. All other grafts contained a
single renal artery and vein without evidence of other
complex vascular anatomy. In the RALDN group, all har-
vested renal grafts had a single renal artery and a single
renal vein. Preoperative donor serum creatinine (0.8 vs.
0.9 mg/dL, P.64) and eGFR values (88.7 vs. 93.4 mL/
min/1.73m2, P.65) were not significantly different be-
tween the 2 groups.
EBL, WIT, and total operative time are reported in Table 2.
EBL was 76.4mL for LDN and 30mL for RALDN, but the
difference did not reach statistical significance (P.07).
Mean WIT was 2.6 minutes for LDN (n15) vs. 3.8 min-
utes for RALDN (n4), P.44. Operative times were avail-
able for 17 of 20 LDN cases and 4 of 5 RALDN cases. Mean
operative time for LDN was 231 minutes while for RALDN
it was 218 minutes, P.61. No intraoperative complica-
tions occurred in either group nor were there any conver-
sions to open surgery.
Postoperative endpoints included donor renal function at
discharge, total MED requirement, and LOS (Table 2).
The mean serum creatinine value (1.3mg/dL for both) and
mean eGFR (53 vs. 59.6mL/min/1.73m2, LDN vs. RALDN)
were similar for both donor groups by day of discharge.
One patient in the RALDN group with a prior history of
heavy preoperative narcotic requirements was excluded
from the postoperative narcotic data pool. The remaining
24 patients were included in the MED analysis that found
a similar narcotic use for both groups (93.5mg vs. 94.6mg
for LDN vs. RALDN respectively, P.97). LOS was 1 day
shorter in duration for LDN at 2.6 days vs. 3.6 days for
RALDN (P.19).
Recipient age at the time of surgery (49.2 vs. 41.6 years,
P.53) and preoperative creatinine (7.0 vs. 8.3mg/dL,
P.42) and eGFR (9.4 vs. 8.0mL/min/1.73 m2, P.44)
were similar between those receiving grafts from LDN and
RALDN donors (Table 1). The average BMI was higher for
those in the RALDN recipient group (29.6 vs. 25, P.04).
Serum creatinine values at 1 week posttransplant was
higher (3.1 mg/dL, n4) vs LDN (1.8mg/dL) and esti-
mated GFR lower for those who underwent RALDN
(36.8mL/min/1.73 m2, n4) vs. LDN (45.7mL/min/
1.73m2), but neither reached statistical significance, P.17
and .26, respectively (Table 3). At 6 months, this disparity
was less apparent with serum creatinine values of
1.4mg/dL for LDN and 1.5mg/dL for RALDN, P.87, and
eGFRs of 53.4mL/min/1.73 m2 for LDN (n14) and
59.8mL/min/1.73m2 for RALDN (n4), P.53. After 1
year, recipient creatinine values were similar for both
groups (1.6 vs 1.4mg/dL, LDN vs RALDN, P.50), and
recipient eGFR was higher for RALDN 60.8 vs. 44.3mL/
min/1.73m2 for LDN, P.05. In each group, only one
recipient had a postoperative diagnosis of delayed graft
function (5% vs. 20%, LDN vs. RALDN, P.37).
DISCUSSION
Renal transplantation is the best treatment available for
end-stage renal disease. Living renal transplantation has
Table 2.
Donor Outcomes
LDNa RALDNa P Value
EBLa (mL) 76.4 30 .07
OR Time (min) 231, n17 218, n4 .61
WITa (min) 2.6, n15 3.8, n4 .44
MEDa (mg) 93.5 94.6, n4 .97
LOSa (days) 2.6 3.6 .19
Postoperative Creatinine
at Discharge (mg/dL)
1.3 1.3 .84
Postoperative eGFR
(mL/min/1.73m2)
53 59.6 .26
aLDN – Laparoscopic Donor Nephrectomy; RALDN – Robotic-
assisted Laparoscopic Donor Nephrectomy; EBL – Estimated
Blood Loss; WIT – Warm Ischemia Time; MED – Morphine
Equivalent Dose; LOS – Length of Stay; eGFR – estimated glo-
merular filtration rate.
Table 3.
Recipient Outcomes
LDNa RALDNa P
Value
Posttransplant Creatinine
(mg/dL) and Posttransplant
eGFRa (mL/min/1.73m2)
1 week Creatinine 1.8 3.1, n4 .17
1 week eGFR 45.7 36.8, n4 .26
6 months Creatinine 1.4, n14 1.5, n4 .87
6 months eGFR 53.4, n14 59.8, n4 .53
1 year Creatinine 1.6, n9 1.4 .50
1 year eGFR 44.3, n9 60.8 .05
DGFa 1/20 1/5 .37
aLDN – Laparoscopic Donor Nephrectomy; RALDN – Robotic-
assisted Laparoscopic Donor Nephrectomy; DGF – Delayed
Graft Function; eGFR – estimated glomerular filtration rate.
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greatly expanded the number of kidneys available for the
donor pool.19 Laparoscopic donor nephrectomy has be-
come the gold standard procedure for those who wish to
be living kidney donors.20 The operation has been proven
to be technically feasible and demonstrates outcomes clin-
ically comparable to those of open procedures.5 In addi-
tion, right-sided donor nephrectomy has also been shown
to be equally efficacious in comparison to traditional left-
sided harvests.16
RALDN is a technical variation of LDN that may provide
for a shorter learning curve compared to that of standard
laparoscopic nephrectomy.21–23 While the concern of uti-
lizing LDN for retrieval of right-sided kidneys resulting in
short renal veins leading to increased incidence of throm-
bosis and graft loss has been well documented, the ad-
vantages of robotic-assisted procedures have been sug-
gested as a conduit to overcome the technical barriers
associated with standard laparoscopy.18 Robotic systems
are theorized to improve upon the limitations of pure
laparoscopic surgery by providing enhanced visibility and
flexibility as well as 3-dimensional vision with superior
dexterity which provides for more efficient dissection of
the renal hilum.23
Advantages of robotic-assisted techniques should theoret-
ically translate into improved donor and recipient out-
comes compared to LDN outcomes. We hypothesized that
robotic-assistance may lead to lower blood loss, shorter
operative times, and improved recipient outcomes. Be-
cause of our extensive prior experience with robotic renal
surgery, we were comfortable with our patient and port
positioning and did not have to overcome these aspects of
the learning curve for this relatively high-stakes proce-
dure. We primarily focused on right-sided RALDN, be-
cause we felt that autonomous dissection of the right
kidney, particularly the upper pole and absence of acces-
sory venous systems (ie, no lumbar vein or adrenal vein to
identify or dissect), was easier compared to the left and
thus was a more appropriate side on which to attempt our
initial robotic-assisted donor nephrectomy procedures. If
we had been able to demonstrate a significant positive
impact of robotic-assistance, we would have proceeded to
attempt left-sided robotic donor nephrectomies, with its
higher colonic flexure and more complex accessory ve-
nous system.
In our study, EBL and OR times, 2 of the theorized goal
outcomes associated with robotic surgery, showed im-
provement, but these results did not reach statistical sig-
nificance. Alternatively, LOS and recipient eGFR at dis-
charge were slightly worse with RALDN, although these
results also did not reach statistical significance. Although
serum creatinine levels were similar for both recipient
groups at 1 year, when calculating the eGFR, recipients at
1 year posttransplant was significantly higher for RALDN
patients compared to LDN. In view of the comparable
serum creatinine levels and when considering our rela-
tively small numbers, these results are difficult to interpret
as being a true indication of more durable results with
RALDN over LDN. It must be stressed that short-term
intraoperative factors, such as EBL, OR time, and WIT,
showed no benefit. Other clinical outcomes, including
postoperative narcotic requirements as well as postoper-
ative donor eGFR values were not significantly different
between LDN and RALDN, demonstrating equal feasibility
between both techniques (Tables 2 and 3). In all pa-
tients, the operation was kept minimally invasive. There
were no intraoperative complications including bleeding
or bowel injuries, which can be associated with laparo-
scopic surgery.24,25 Understandably, these results may
have been influenced by our young donor population
with relatively low BMIs and low renal vascular complex-
ity. In fact, our patient group had a lower incidence of
dual vessels than the series published by Fettouh et al26
who reported on 79 patients, approximately 20% of whom
had multiple renal arteries or veins. However, their com-
plication rate was also very low and their mean EBL was
65mL, demonstrating that LDN can be safe even for do-
nors with vascular anomalies.
The increased WIT in our RALDN group is undoubtedly
related to the inefficacy of hilar control with extirpative
robotic renal surgery. At the time of this manuscripts’
writing, the da Vinci Robotic Surgical System does not
yet have a stapler attachment, leaving the only devices
for hilar control for the robotic surgeon to be either
suture ligation or Hem-o-lok clip application, 2 meth-
ods that we believe to be unacceptably inferior. As a
result, at the time of vessel ligation during RALDN, we
had an assistant pass a vascular stapler through an
accessory port to ligate the renal artery and vein, a
process that was admittedly more awkward than with
the laparoscopic counterpart, and thus may have trans-
lated into longer WITs. However, this difference did not
reach statistical significance in our study nor did it
adversely affect recipient allograft function. In addition,
our results compare favorably to RALDNs performed by
Hubert et al19 that showed an average WIT of 5.8 min-
utes in their cohort of patients. Still, in our study there
was no improvement in the incidence of delayed graft
function between the 2 groups, which occurred only
once in either patient population.
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Finally, the higher costs associated with robotics should
be a determining factor when evaluating surgical tech-
niques utilized in urologic surgery.27 When laparoscopic
radical nephrectomy has been compared with open pro-
cedures, studies have shown that laparoscopy contributes
an approximate $2000 to total hospital costs.28 A financial
analysis specific to robotic surgery demonstrated that ro-
botic-assistance incurs an additional $3200 in total hospi-
tal care dollars.29 These extra costs may be driven down if
postoperative patient expenses can be reduced or if return
to normal activity is faster. As robotic-assistance did not
significantly improve postoperative patient parameters in
our study, the higher costs associated with the use of
robotics in our era of health-care financial awareness is
another significant determining factor against RALDN.
Our study has several limitations that must be acknowl-
edged. First, our low absolute number of patients can limit
the demonstration of benefit of robotic-assisted donor
nephrectomy. However, the absolute percentage of right-
sided donor nephrectomies performed at our institution
(16%) far exceeds the reported percentage of right-sided
LDNs at several other major transplant centers in the
United States.30 A larger number of study patients may
drive some factors that did not reach statistical significance
in our study to eventually show a difference between the
2 techniques. Second, a retrospective design inherently
introduces selection bias in the study groups. Third, the
theoretical advantages of RALDN over LDN during lapa-
roscopic dissection may be better displayed in donor
patients with complex renal vascular anatomy. In our
study population, no donor patient in the RALDN group
had 1 renal artery or vein. Patients with multiple renal
vessels may be better suited for RALDN secondary to more
efficient dissection of the renal pedicles compared to LDN,
possibly leading to significantly shorter OR times or less
EBL. Additionally, the addition of more advanced robotic
surgical instrumentation, such as an endovascular stapler,
may have a positive influence on some of the primary
endpoints in our study. Finally, postoperative complica-
tions, such as deep vein thrombosis, pulmonary embo-
lism, urinary tract infection, or wound infections were not
reported in either group. Although these are generally
limited in healthy donor patients undergoing minimally
invasive surgery, subtle differences between RALDN and
LDN may impact any or all of these factors.
CONCLUSION
Right-sided living donor nephrectomy with either stan-
dard laparoscopic or robotic-assisted techniques is tech-
nically feasible and safe, demonstrating similar donor and
recipient outcomes, with slightly better recipient eGFR at
1 year for RALDN. Our study, however, did not prove
many of the perceived benefits with the addition of ro-
botic-assistance to LDN. More advanced robotic technol-
ogy and instrumentation will likely attract further evalua-
tion of RALDN. Future prospective studies with a larger
number of patients may better elucidate the potential
benefit of a robotic-assisted approach during minimally
invasive donor nephrectomy.
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